Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms
Urologia Internationalis · 2023
DOI: 10.1159/000534148 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Urologia Internationalis, 2023. Verfasst von Fabio Crocerossa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Curcumin, gamma-Cyclodextrins, Lower Urinary Tract Symptoms. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms (LUTSs) in males. Curcumin exhibits anti-inflammatory and anti-tumor properties which may be effective for BPH. This multi-arm observational study evaluated the real-world efficacy of QURMIN® (Gamma-cyclodextrin-curcumin Complex-CAVACURMIN®) as single or combination therapy for BPH.
Methods
Men with moderate-severe LUTS/BPH, receiving a 6-month supplementation with QURMIN® alone or in combination with BPH-specific medication were propensity score matched with patients not taking curcumin and then divided into subgroups based on concomitant baseline treatment. Cohorts were compared in the 6-month variation of IPSS, quality of life (IPSS-QoL), Benign Prostatic Hyperplasia Impact Index (BII) and uroflowmetry parameters. Curcumin tolerability was evaluated in terms of discontinuations and adverse effects.
Results
The 1:1 propensity score matching resulted in a treatment-naïve (n = 152), an alpha-blocker only (AB) (n = 138) and AB + 5-alpha reductase inhibitors (5-ARIs) (n = 78) subgroup. After 6 months, drug-naïve patients taking curcumin reported significant improvement in IPSS-storage (−3.9, p < 0.001), IPSS-voiding (−2.0, p = 0.011), IPSS-total (−5.9, p < 0.001), IPSS-QoL (−3.9, p < 0.001), BII (−2.0, p < 0.001), Qmax (+3.1 mL/s, p < 0.001), Qmean (+1.9 mL/s, p = 0.005), post-void residual volume (−7.7 mL, p < 0.001), and PSA (−0.3 ng/mL, p = 0.003), compared to controls. Patients taking ABs and curcumin showed improvement in IPSS-storage (−2.7, p < 0.001), IPSS-voiding (−1.3, p = 0.033), IPSS-total (−3.5, p < 0.001), IPSS-QoL (−1.1, p = 0.004), BII (−1.7, p = 0.006), Qmax (+1.0 mL/s, p = 0.006), and PSA (−0.2 ng/mL, p = 0.01). Patients taking curcumin and AB + 5-ARI showed improvement in IPSS-storage (−1.3, p = 0.007), IPSS-total (−1.6, p = 0.034), IPSS-QoL (−1.1, p < 0.001), and BII (−2.0, p < 0.001). No adverse reactions were reported for curcumin supplementation.
Conclusion
QURMIN® (CAVACURMIN®) led to significant improvements in symptom burden, uroflow parameters, and QoL, without significant additional side effects, thus proving to be a potential new treatment for BPH, either as a single therapy or in addition to standard treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy.
- Department of Urology, IMED Hospitals, Valencia, Spain.
- Department of Urology, University of Bari, Bari, Italy.
- Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.
- Department of Urology, Mantua Hospital, Mantua, Italy.
Zitieren
APA
Crocerossa, F., Cantiello, F., Bagalá, L., Sicoli, F., Carbonara, U., Manfredi, C., Falagario, U., Veccia, A., Pandolfo, S. D., Napolitano, L., Ferro, M., Di Dio, M., Mondaini, N., & Damiano, R. (2023). Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms. Urologia Internationalis. https://doi.org/10.1159/000534148
Vancouver
Crocerossa F, Cantiello F, Bagalá L, Sicoli F, Carbonara U, Manfredi C, et al. Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms. Urologia Internationalis. 2023. doi:10.1159/000534148
BibTeX
@article{Crocerossa2023,
author = {Crocerossa, Fabio and Cantiello, Francesco and Bagalá, Lorenzo and Sicoli, Francesco and Carbonara, Umberto and Manfredi, Celeste and Falagario, Ugo and Veccia, Alessandro and Pandolfo, Savio D and Napolitano, Luigi and Ferro, Matteo and Di Dio, Michele and Mondaini, Nicola and Damiano, Rocco},
title = {Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms},
journal = {Urologia Internationalis},
year = {2023},
doi = {10.1159/000534148}
}
EUVIMED